76098-89-0Relevant articles and documents
Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed: De novo design model
Morris, Aaron,McCorkindale, William,Drayman, Nir,Chodera, John D.,Tay, Sava?,London, Nir,Lee, Alpha A.
, p. 5909 - 5912 (2021/06/27)
The SARS-CoV-2 main viral protease (Mpro) is an attractive target for antivirals given its distinctiveness from host proteases, essentiality in the viral life cycle and conservation across coronaviridae. We launched the COVID Moonshot initiative to rapidly develop patent-free antivirals with open science and open data. Here we report the use of machine learning for de novo design, coupled with synthesis route prediction, in our campaign. We discover novel chemical scaffolds active in biochemical and live virus assays, synthesized with model generated routes. This journal is
NOVEL HETEROARYL DERIVATIVE
-
Page/Page column 41, (2008/06/13)
A heteroaryl derivative of the formula (1): (wherein Ring Z is an optionally substituted heteroaryl, R1 is a carboxyl group or an alkoxycarbonyl group, etc., W1 and W2 are an optionally substituted lower alkylene, Ar1 is an optionally substituted arylene or an optionally substituted heteroarylene, W3 is a single bond, a lower alkylene, a lower alkenylene, etc., W4 is a single bond, -NR10-, etc., Ar2 is an optionally substituted aryl or an optionally substituted heteroaryl), or a prodrug thereof, or a pharmaceutically acceptable salt thereof.